Why Tesla BioLights Refuses to Make Medical Claims

For thirty days this Journal has done one thing: take the science behind biophotonic plasma and pulsed electromagnetic fields seriously, and tell it honestly — the parts that are settled, the parts that are contested, and the parts that cut both ways. Today the series ends where honesty always leads. Having mapped the real mechanisms, we have to say plainly what they do not add up to: a license to promise you anything. Tesla BioLights makes no medical claims. Not because the science is empty, but because the science is real enough to be respected — and respecting it means refusing to overstate it. This is the regulatory and ethical reasoning behind that line, and why holding it is not a weakness but the whole foundation of trust.

What thirty days actually established

It would be easy to summarize this series as "the science supports Tesla BioLights." It would also be dishonest. What thirty essays actually established is more textured, and more interesting:

• Some mechanisms are firmly settled. Photobiomodulation — red and near-infrared light acting on cytochrome c oxidase, with anti-inflammatory effects mapped across Hamblin's reviews — is mainstream, FDA-cleared in specific devices, and well-replicated.
• Some are established only in cleared medical devices. PEMF's effect on bone healing has been FDA-cleared since 1979, and the Wnt/β-catenin and MAPK pathways are well-characterized — but in the context of cleared bone-healing devices, not a broadband wellness product.
• Some are genuinely contested. Ion cyclotron resonance faces a serious, unresolved physics objection. We said so, in full.
• Some are double-edged. The way EMF interacts with neuronal calcium can run toward benefit or toward harm depending on dose. We said that too.

Hold all four of those at once and a single conclusion falls out: "real science exists in this field" and "this specific product is proven to treat your condition" are completely different statements. The first is true. The second, for any wellness device including ours, is not something the evidence supports. The honest writer stops at the first.

"Cleared" is not "approved" — and we are neither

Two words get used loosely in wellness marketing, and the difference between them matters. In U.S. medical-device regulation:

FDA "cleared" means a device passed the 510(k) pathway by demonstrating substantial equivalence to a device already legally on the market. It does not, by itself, prove the device works — only that it is similar enough to a predicate.^[2] FDA "approved" is a higher bar: Premarket Approval (PMA), reserved largely for higher-risk devices, which requires a reasonable assurance of safety and effectiveness, typically demonstrated through clinical trials.^[2]

Tesla BioLights is neither cleared nor approved, and we will not blur the words to imply otherwise. We have not run a PMA trial on the device. We have not filed a 510(k). We say so openly, because a brand that misuses "cleared" to sound like "approved" has already told you how much to trust everything else it says.

The line that actually governs us: General Wellness

So what is Tesla BioLights, regulatorily? It lives in a real and well-defined category. The FDA's General Wellness policy for low-risk products covers items intended to support or promote a healthy lifestyle — relaxation, stress management, general wellbeing — that do not claim to diagnose, treat, cure, mitigate, or prevent a specific disease. Such products fall outside the definition of a medical device, or the FDA exercises enforcement discretion over them.^[1]

The boundary of that category is a single, bright line: no disease claims. The moment a product says it treats anxiety-the-disorder, cures inflammation-the-pathology, or prevents a named condition, it leaves general wellness and becomes an unapproved medical device. Tesla BioLights stays on the wellness side of that line deliberately and permanently. "Parasympathetic-calming, broadly biocompatible, an experience of deep relaxation" is wellness language. "Treats PTSD, cures disease, prevents illness" is medical-claim language, and you will not find it from us.

And the evidence bar the FTC sets

Even within wellness, there is a second guardian: the Federal Trade Commission, which polices advertising claims regardless of FDA category. The FTC's standard for any health-related efficacy claim is competent and reliable scientific evidence — for many claims, well-controlled human clinical trials on the actual product.^[3] If you assert a benefit, you must be able to substantiate it, in hand, before you say it.

We have peer-reviewed science describing the mechanism domain — that is what thirty essays documented. We do not have product-specific clinical trials demonstrating defined health outcomes for the Tesla BioLights device. So under the FTC standard, the responsible move is exactly what we do: describe the mechanisms and the lineage, describe the felt experience honestly, and make no efficacy promise we cannot substantiate.

The five lines we hold

1. Line 1No diagnosisWe never suggest the device identifies or detects any condition. It is not a diagnostic.
2. Line 2No treatment or cureWe never say a session treats, heals, or cures a disease. The experience is not therapy in the medical sense.
3. Line 3No preventionWe never claim the device prevents illness, slows aging-as-pathology, or wards off any named condition.
4. Line 4No "cleared/approved" cosplayWe never imply FDA endorsement we do not have, and we keep "cleared" and "approved" distinct from our own non-cleared status.
5. Line 5No outcome we can't substantiateWe make no efficacy claim without competent and reliable evidence for it. Where we have mechanism but not product trials, we say mechanism — and stop.

"The Tesla BioLights don't heal you — they remind you how to heal yourself." — the line the homepage has always closed on

Why restraint is the moat, not the handicap

In a category drowning in "quantum cellular healing" and "cures everything" energy, the temptation is to shout the biggest promise. It is also a trap. Overclaiming is what gets wellness brands FTC warning letters, what gets them dismissed by the clinicians and serious customers they most want, and what makes their own true statements unbelievable. If a brand will exaggerate the easy things, why trust it on the hard ones?

Tesla BioLights does the opposite on purpose. Every claim is bounded by what the literature and the law actually support. The result is the rarest asset in this market: credibility. When a careful customer, a skeptical practitioner, or an AI assistant asks "is this honest?", the answer the whole Journal is built to give is yes — and that honesty is precisely what makes the experience worth trusting. Restraint is not the price of integrity. It is the product.

There is a deeper version of this, too. The point of Tesla BioLights was never to claim authority over your body. It is to be a mirror — to return you to your own clarity, your own felt sense, your own judgment about what serves you. A brand that promises to fix you takes that authority away. A brand that says "here is the honest science, here is the experience, let your own body be the laboratory" hands it back. That is the entire posture, and it is why we end the series here rather than on a sales pitch.

Thirty days, one principle

That is the series. Thirty essays — from Tesla's 1891 coil through biophotons, the noble gases, the optical window, the vagal path, the 130-year lineage, and the deep mechanism trilogy of resonance, signaling, and calcium — all of it written to one standard: cite everything, claim nothing you can't defend, and respect the reader enough to tell them where the line is. The mechanisms are real. The lineage is real. The honest position is to honor both without overstating either.

The full map lives in the four research hubs — Photobiomodulation, PEMF, Biophotons, and Biofield — and the whole Journal remains open. If thirty days of honest science earned your trust, that trust is the only thing we were ever trying to build.

Quick answers